China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of Target-Controlled Infusion with Etomidate versus Propofol Combined with Intravenous Esketamine for Ultrasound-Guided Segmental Mastectomy in Benign Breast Tumors: A Single-Center, Randomized, Controlled Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131912
Registration Time: 2026/09/07
Type: Interventional study
Primary Sponsor: The Third Affiliated Hospital of Southern Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338691
Published by HT Digital Content Services with permission from Health Daily Digest....